Endovascular Embolization of the Uterine Arteries in Giant Uterine Fibroids

Choosing a treatment option for uterine fibroids is today one of the most relevant problems in gynecological practice. Thanks to the success of modern medicine and the increased level of the population’s culture, female patients seek medical help without waiting for the tumor to acquire significant sizes. However, in practice, there are cases when fibroids reach gigantic sizes. Hysterectomy is a traditional approach to treating uterine fibroids of these sizes according to the current clinical guidelines. The introduction of new high-tech treatments, such as uterine artery embolization, has led to a revision of radical surgery, by giving preference to alternative approaches especially in cases where the patient desires to preserve the reproductive organ. The paper describes a clinical case that confirms an individual approach to choosing a treatment option towards organ-sparing surgery for giant uterine fibroids. The use of endovascular embolization of the uterine arteries as a treatment for giant uterine fibroids is shown to be justified as an organ-sparing surgery if the patient desires to preserve reproductive function.

1. Moss JG, Cooper KG, Khaund A, et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. BJOG. 2011; 118(8): 936–44. https://doi.org/10.1111/j.1471-0528.2011.02952.x.

2. de Bruijn AM, Ankum WM, Reekers JA, et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. Obstet Gynecol Survey. 2016; 71(11): 653–5. https://doi.org/10.1097/01.ogx.0000503331.67536.b9.

3. Smeets AJ, Nijenhuis RJ, van Rooij WJ. Uterine artery embolization in patients with a large fibroid burden: long-term clinical and MR follow-up. Cardiovasc Intervent Radiol. 2010; 33(5): 943–8. https://doi.org/10.1007/s00270-009-9793-2.

4. Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev. 2013; 34(1): 130–62. https://doi.org/10.1210/er.2012-1043.

5. Silberzweig JE, Powell DK, Matsumoto AH, Spies JB. Management of uterine fibroids: a focus on uterine-sparing interventional techniques. Radiology. 2016; 280(3): 675–92. https://doi.org/10.1148/radiol.2016141693.

6. Goodwin SC, Spies JB, Worthington-Kirsch R, et al. Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry. Obstet Gynecol. 2008; 111(1): 22–33. https://doi.org/10.1097/01.AOG.0000296526.71749.c9.

7. Llewellyn O, Patel NR, Mallon D, et al. Uterine artery embolisation for women with giant versus non-giant uterine fibroids: a systematic review and meta-analysis. Cardiovasc Intervent Radiol. 2020; 43(5): 684–93. https://doi.org/10.1007/s00270-019-02359-7.

8. Vashisht A, Studd J, Carey A, Burn P. Fatal septicaemia after fibroid embolisation. Lancet. 1999; 354(9175): 307–8. https://doi.org/10.1016/S0140-6736(99)02987-6.

9. Pelage JP, Le Dref O, Soyer P, et al. Fibroid-related menorrhagia: treatment with superselective embolization of the uterine arteries and midterm follow-up. Radiology. 2000; 215(2): 428–31. https://doi.org/10.1148/radiology.215.2.r00ma11428.

10. Katsumori T, Nakajima K, Mihara T. Is a large fibroid a high-risk factor for uterine artery embolization? Am J Roentgenol. 2003; 181(5): 1309–14. https://doi.org/10.2214/ajr.181.5.1811309.

11. Çakır V, Ballı Ö. Arterial embolization in large uterine fibroids: a 4-year single center experience. Int J Sci Res Manag. 2019; 7(10): 268–74. https://doi.org/10.18535/ijsrm/v7i10.mp01.

12. Nasser F, Boueri Affonso B, Glauber de Jesus-Silva S, et al. Embolização de mioma uterino em mulheres portadoras de miomas volumosos. Rev Bras Ginecol Obstet. 2010; 32(11): 530–5 (in Spain). https://doi.org/10.1590/S0100-72032010001100003.